Axons are injured by antigen-specific CD8+ T cells through a MHC class I- and granzyme B-dependent mechanism

Brian M. Sauer, William F. Schmalstieg, Charles L Howe

Research output: Contribution to journalArticle

18 Citations (Scopus)

Abstract

Axon injury is a central determinant of irreversible neurological deficit and disease progression in patients with multiple sclerosis (MS). CD8+ lymphocytes (CTLs) within inflammatory demyelinated MS lesions correlate with acute axon injury and neurological deficits. The mechanisms of these correlations are unknown. We interrogated CTL-mediated axon injury using the transgenic OT-I antigen-specific CTL model system in conjunction with a chambered cortical neuron culture platform that permitted the isolated manipulation of axons independent of neuron cell bodies and glia. Interferon gamma upregulated, through a dose dependent mechanism, the axonal expression of functional major histocompatibility complex class I (MHC I) molecules competent to present immunologically-relevant antigens derived from endogenously expressed proteins. Antigen-specific CTLs formed cytotoxic immune synapses with and directly injured axons expressing antigen-loaded MHC I molecules. CTL-mediated axon injury was mechanistically dependent upon axonal MHC I antigen presentation, T cell receptor specificity and axoplasmic granzyme B activity. Despite extensive distal CTL-mediated axon injury, acute neuron cell body apoptosis was not observed. These findings present a novel model of immune-mediated axon injury and offer anti-axonal CTLs and granzyme B as targets for the therapeutic protection of axons and prevention of neurological deficits in MS patients.

Original languageEnglish (US)
Pages (from-to)194-205
Number of pages12
JournalNeurobiology of Disease
Volume59
DOIs
StatePublished - Nov 2013

Fingerprint

CD8 Antigens
Granzymes
Axons
T-Lymphocytes
Wounds and Injuries
Major Histocompatibility Complex
Multiple Sclerosis
Neurons
Antigens
T-Cell Antigen Receptor Specificity
Histocompatibility Antigens Class I
Antigen Presentation
Neuroglia
Synapses
Interferon-gamma
Disease Progression
Lymphocytes
Apoptosis

Keywords

  • Axon injury
  • CD8 T cell
  • Granzyme B
  • Interferon gamma (IFNγ)
  • Major histocompatibility complex class I (MHC I)
  • Microfluidic neuron culture
  • Multiple sclerosis
  • OT-I

ASJC Scopus subject areas

  • Neurology

Cite this

Axons are injured by antigen-specific CD8+ T cells through a MHC class I- and granzyme B-dependent mechanism. / Sauer, Brian M.; Schmalstieg, William F.; Howe, Charles L.

In: Neurobiology of Disease, Vol. 59, 11.2013, p. 194-205.

Research output: Contribution to journalArticle

@article{2751a8cde584497b9754e2b2121c20a2,
title = "Axons are injured by antigen-specific CD8+ T cells through a MHC class I- and granzyme B-dependent mechanism",
abstract = "Axon injury is a central determinant of irreversible neurological deficit and disease progression in patients with multiple sclerosis (MS). CD8+ lymphocytes (CTLs) within inflammatory demyelinated MS lesions correlate with acute axon injury and neurological deficits. The mechanisms of these correlations are unknown. We interrogated CTL-mediated axon injury using the transgenic OT-I antigen-specific CTL model system in conjunction with a chambered cortical neuron culture platform that permitted the isolated manipulation of axons independent of neuron cell bodies and glia. Interferon gamma upregulated, through a dose dependent mechanism, the axonal expression of functional major histocompatibility complex class I (MHC I) molecules competent to present immunologically-relevant antigens derived from endogenously expressed proteins. Antigen-specific CTLs formed cytotoxic immune synapses with and directly injured axons expressing antigen-loaded MHC I molecules. CTL-mediated axon injury was mechanistically dependent upon axonal MHC I antigen presentation, T cell receptor specificity and axoplasmic granzyme B activity. Despite extensive distal CTL-mediated axon injury, acute neuron cell body apoptosis was not observed. These findings present a novel model of immune-mediated axon injury and offer anti-axonal CTLs and granzyme B as targets for the therapeutic protection of axons and prevention of neurological deficits in MS patients.",
keywords = "Axon injury, CD8 T cell, Granzyme B, Interferon gamma (IFNγ), Major histocompatibility complex class I (MHC I), Microfluidic neuron culture, Multiple sclerosis, OT-I",
author = "Sauer, {Brian M.} and Schmalstieg, {William F.} and Howe, {Charles L}",
year = "2013",
month = "11",
doi = "10.1016/j.nbd.2013.07.010",
language = "English (US)",
volume = "59",
pages = "194--205",
journal = "Neurobiology of Disease",
issn = "0969-9961",
publisher = "Academic Press Inc.",

}

TY - JOUR

T1 - Axons are injured by antigen-specific CD8+ T cells through a MHC class I- and granzyme B-dependent mechanism

AU - Sauer, Brian M.

AU - Schmalstieg, William F.

AU - Howe, Charles L

PY - 2013/11

Y1 - 2013/11

N2 - Axon injury is a central determinant of irreversible neurological deficit and disease progression in patients with multiple sclerosis (MS). CD8+ lymphocytes (CTLs) within inflammatory demyelinated MS lesions correlate with acute axon injury and neurological deficits. The mechanisms of these correlations are unknown. We interrogated CTL-mediated axon injury using the transgenic OT-I antigen-specific CTL model system in conjunction with a chambered cortical neuron culture platform that permitted the isolated manipulation of axons independent of neuron cell bodies and glia. Interferon gamma upregulated, through a dose dependent mechanism, the axonal expression of functional major histocompatibility complex class I (MHC I) molecules competent to present immunologically-relevant antigens derived from endogenously expressed proteins. Antigen-specific CTLs formed cytotoxic immune synapses with and directly injured axons expressing antigen-loaded MHC I molecules. CTL-mediated axon injury was mechanistically dependent upon axonal MHC I antigen presentation, T cell receptor specificity and axoplasmic granzyme B activity. Despite extensive distal CTL-mediated axon injury, acute neuron cell body apoptosis was not observed. These findings present a novel model of immune-mediated axon injury and offer anti-axonal CTLs and granzyme B as targets for the therapeutic protection of axons and prevention of neurological deficits in MS patients.

AB - Axon injury is a central determinant of irreversible neurological deficit and disease progression in patients with multiple sclerosis (MS). CD8+ lymphocytes (CTLs) within inflammatory demyelinated MS lesions correlate with acute axon injury and neurological deficits. The mechanisms of these correlations are unknown. We interrogated CTL-mediated axon injury using the transgenic OT-I antigen-specific CTL model system in conjunction with a chambered cortical neuron culture platform that permitted the isolated manipulation of axons independent of neuron cell bodies and glia. Interferon gamma upregulated, through a dose dependent mechanism, the axonal expression of functional major histocompatibility complex class I (MHC I) molecules competent to present immunologically-relevant antigens derived from endogenously expressed proteins. Antigen-specific CTLs formed cytotoxic immune synapses with and directly injured axons expressing antigen-loaded MHC I molecules. CTL-mediated axon injury was mechanistically dependent upon axonal MHC I antigen presentation, T cell receptor specificity and axoplasmic granzyme B activity. Despite extensive distal CTL-mediated axon injury, acute neuron cell body apoptosis was not observed. These findings present a novel model of immune-mediated axon injury and offer anti-axonal CTLs and granzyme B as targets for the therapeutic protection of axons and prevention of neurological deficits in MS patients.

KW - Axon injury

KW - CD8 T cell

KW - Granzyme B

KW - Interferon gamma (IFNγ)

KW - Major histocompatibility complex class I (MHC I)

KW - Microfluidic neuron culture

KW - Multiple sclerosis

KW - OT-I

UR - http://www.scopus.com/inward/record.url?scp=84883019402&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84883019402&partnerID=8YFLogxK

U2 - 10.1016/j.nbd.2013.07.010

DO - 10.1016/j.nbd.2013.07.010

M3 - Article

C2 - 23899663

AN - SCOPUS:84883019402

VL - 59

SP - 194

EP - 205

JO - Neurobiology of Disease

JF - Neurobiology of Disease

SN - 0969-9961

ER -